As the aging population grows in the U.S., the number of Medicare beneficiaries has increased but the number of glaucoma procedures has declined, according to a study.“The main message is that the landscape of glaucoma surgery is changing,” study author Pradeep Y. Ramulu, MD, PhD, told Ocular Surgery News. “Before, trabeculectomy was, far and away, the primary surgery for glaucoma. Now, there are more cyclophotocoagulations performed than primary trabeculectomies, and most of these are done endoscopically. Also, it is interesting to see that several minimally invasive glaucoma procedures, such as endoscopic cyclophotocoagulation and canaloplasty in particular, are becoming more and more common.”
Implantable Miniature Telescope retains positive results in 5-year follow-up
The Implantable Miniature Telescope showed favorable safety and efficacy outcomes for treating end-stage age-related macular degeneration over the long term, particularly in patients younger than 75 years old, according to a study.The IMT (VisionCare Ophthalmic Technologies) is a fixed-focus telescopic system that enlarges visual objects in a patient’s central visual field.
Cataract surgery embodies power of innovation cycle
The innovation cycle is critical to product development and also to enhancing care delivery. In the innovation cycle, an unmet need is recognized, human and financial capital are applied to provide a solution to the unmet need, failure is always encoun…
Digital markerless system improves predictability for astigmatism correction
A digital markerless method may be more accurate for toric IOL alignment than manual ink marking for astigmatism correction during cataract surgery, according to a presentation at the American Society of Cataract and Refractive Surgery annual meeting.I…
Electronic health records may improve financial returns, workflow efficiency
The use of electronic health records may result in significant financial returns and workflow efficiency for practices, according to a report.The prospective financial analysis, reported in Ophthalmology, evaluated data that affected cash flows relevan…
InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal”
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal”